Seiji Niho

7.6k citations
216 papers · 5.2k · 2 hit papers · h-index 37

Impact in

  • Oncology top 0.5%
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Lung Cancer Treatments and Mutations 84
    • Lung Cancer Diagnosis and Treatment 43
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 14
    • Gastric Cancer Management and Outcomes 12
    • Lung Cancer Research Studies 57
    • Colorectal Cancer Treatments and Studies 24
    • Cancer Immunotherapy and Biomarkers 13

Seiji Niho

204 papers receiving 5.1k citations

Seiji Niho's Hit Papers

Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer and EGFR-Activating Mutations 2018 · 332 citations
3320+3+6Years since publication250500750

Peers

Seiji Niho
Comparison fields: 5 of 106
  • Oncology 2.3k
  • Pulmonary and Respiratory Medicine 2.5k
  • Cancer Research 415
  • Neurology 389
  • Epidemiology 615
Replace Kiyotaka Yoh with:
Kiyotaka Yoh Japan
Hiroshi Nokihara Japan
Haruhiko Kondo Japan
Kazumasa Noda Japan
Inderpal S. Sarkaria United States
Giuseppe Procopio Italy
Masahiko Higashiyama Japan
Ignacio Durán Spain
Caroline Caramella France
Antonio Chella Italy
Seiji Niho relative to Kiyotaka Yoh Japan Kiyotaka Yoh's profile →
Citations per field
00.5×1.7×
Kiyotaka Yoh · 1×
Citations per year

Countries citing papers authored by Seiji Niho

Since Specialization
Citations

This map shows the geographic impact of Seiji Niho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seiji Niho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seiji Niho more than expected).

Fields of papers citing papers by Seiji Niho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seiji Niho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seiji Niho. The network helps show where Seiji Niho may publish in the future.

Co-authors

The 25 scholars most cited alongside Seiji Niho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Seiji Niho Line = papers co-authored together Seiji Niho links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 216 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial
Hit paper breakdown →
2017880
2
Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer and EGFR-Activating Mutations
Hit paper breakdown →
2018332
3 2016142
4 2020140
5 2013119
6 2005118
7 2004108
8 2014105
9 200890
10 202088
11 201883
12 201976
13 201974
14 200373
15
Monoclonality of both pale cells and cuboidal cells of sclerosing hemangioma of the lung.
199870
16 199968
17 200467
18 200366
19 201462
20 200060

About Seiji Niho

Seiji Niho is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Epidemiology, Molecular Biology and Surgery, having authored 216 papers that have together received 5.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (84 papers), Lung Cancer Research Studies (57 papers), Lung Cancer Diagnosis and Treatment (43 papers), Colorectal Cancer Treatments and Studies (24 papers), Neuroendocrine Tumor Research Advances (22 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Gastric Cancer Management and Outcomes (12 papers). The work is most often cited by research in Oncology (2.3k citations), Pulmonary and Respiratory Medicine (2.5k citations), Cancer Research (415 citations), Neurology (389 citations) and Epidemiology (615 citations). Seiji Niho has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Kōichi Goto, Kiyotaka Yoh, Hironobu Ohmatsu, Yutaka Nishiwaki, Shingo Matsumoto, Kaoru Kubota, Shigeki Umemura, Yuichiro Ohe, Kazuhiko Nakagawa and Genichiro Ishii. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, Annals of Oncology, Journal of Thoracic Oncology and Japanese Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact